{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:06:38Z","timestamp":1788930398987,"version":"build-2803163510"},"reference-count":47,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.3201\/eid3014.240296","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:43:17Z","timestamp":1731372197000},"source":"Crossref","is-referenced-by-count":7,"title":["Common Patterns and Unique Threats in Antimicrobial Resistance as Demonstrated by Global Gonococcal Surveillance"],"prefix":"10.3201","volume":"30","author":[{"given":"Adriana","family":"Le Van","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuel","family":"Sandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Dozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn V.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krit","family":"Harncharoenkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nanava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Akhvlediani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya D.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Agingu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis K.","family":"Byarugaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Wabwire-Mangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kibuuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Erima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope O.","family":"Kabatasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiki","family":"Attram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dutsadee","family":"Peerapongpaisarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilawan","family":"Oransathit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wirote","family":"Oransathit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umaporn","family":"Suksawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woradee","family":"Lurchachaiwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Sriplienchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonlawat","family":"Boonyalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneerat","family":"Somsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithinart","family":"Chaitaveep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Jerse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Garges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3014.240296-202411011516-R1","unstructured":"World Health Organization. Multi-drug resistant gonorrhoea [cited 2024 Jul 4]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/multi-drug-resistant-gonorrhoea"},{"key":"key-10.3201\/eid3014.240296-202411011516-R2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/OLQ.0000000000001355","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018.","volume":"48","author":"Kreisel","year":"2021","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid3014.240296-202411011516-R3","unstructured":"Centers for Disease Control and Prevention. CDC changes recommendations for gonorrhea treatment due to drug resistance [cited 2007 Apr 12]. https:\/\/archive.cdc.gov\/www_cdc_gov\/media\/pressrel\/2007\/r070412a_1697124700.htm"},{"key":"key-10.3201\/eid3014.240296-202411011516-R4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jgar.2020.10.022","article-title":"Gonorrhoea treatment combined with population-level general cephalosporin and quinolone consumption may select for Neisseria gonorrhoeae antimicrobial resistance at the levels of NG-MAST genogroup: An ecological study in Europe.","volume":"23","author":"Kenyon","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"key-10.3201\/eid3014.240296-202411011516-R5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021.","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid3014.240296-202411011516-R6","unstructured":"World Health Organization. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: The Organization; 2021."},{"key":"key-10.3201\/eid3014.240296-202411011516-R7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3014.240296-202411011516-R8","doi-asserted-by":"publisher","first-page":"2200803","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200803","article-title":"Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022.","volume":"27","author":"Day","year":"2022","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid3014.240296-202411011516-R9","doi-asserted-by":"publisher","first-page":"21659","DOI":"10.1038\/s41598-021-00675-y","article-title":"Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand.","volume":"11","author":"Kueakulpattana","year":"2021","journal-title":"Sci Rep"},{"key":"key-10.3201\/eid3014.240296-202411011516-R10","unstructured":"Centers for Disease Control and Prevention. AMR gonorrhea: two cases of concern identified [cited 2023 Jan 23]. https:\/\/archive.cdc.gov\/#\/details?url=https:\/\/www.cdc.gov\/std\/dstdp\/dcl\/2023-01-19-bachmann-amr-gonorrhea.htm"},{"key":"key-10.3201\/eid3014.240296-202411011516-R11","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019 [cited 2019 Nov 13]. https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats"},{"key":"key-10.3201\/eid3014.240296-202411011516-R12","unstructured":"World Health Organization. Diagnostics for gonococcal antimicrobial resistance [cited 2023 Jan 23]. https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/stis\/testing-diagnostics\/diagnostics-for-gonococcal-antimicrobial-resistance"},{"key":"key-10.3201\/eid3014.240296-202411011516-R13","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.","volume":"2","author":"Unemo","year":"2021","journal-title":"Lancet Microbe"},{"key":"key-10.3201\/eid3014.240296-202411011516-R14","unstructured":"National Academies of Sciences, Engineering, and Medicine; Vermund SH, Geller AB, and Crowley JS, editors. Sexually transmitted infections: adopting a sexual health paradigm. Washington: The National Academies Press; 2021. 10.17226\/25955"},{"key":"key-10.3201\/eid3014.240296-202411011516-R15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/milmed\/usab407","article-title":"Sexually transmitted infections in the U.S. military: a sexual health paradigm to address risk behaviors, unintended pregnancy, alcohol use, and sexual trauma.","volume":"187","author":"Boyer","year":"2022","journal-title":"Mil Med"},{"key":"key-10.3201\/eid3014.240296-202411011516-R16","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1089\/jwh.2010.2399","article-title":"Lifetime sexual assault and cervical cytologic abnormalities among military women.","volume":"20","author":"Sadler","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"key-10.3201\/eid3014.240296-202411011516-R17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/milmed\/usy431","article-title":"Biomedical response to Neisseria gonorrhoeae and other sexually transmitted infections in the US military.","volume":"184","author":"Garges","year":"2019","journal-title":"Mil Med"},{"key":"key-10.3201\/eid3014.240296-202411011516-R18","first-page":"25","article-title":"The U.S. military\u2019s Neisseria gonorrhoeae resistance surveillance initiatives in selected populations of five countries.","volume":"20","author":"Tsai","year":"2013","journal-title":"MSMR"},{"key":"key-10.3201\/eid3014.240296-202411011516-R19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.7205\/MILMED-D-13-00137","article-title":"Expanded sexually transmitted infection surveillance efforts in the United States military: a time for action.","volume":"178","author":"S\u00e1nchez","year":"2013","journal-title":"Mil Med"},{"key":"key-10.3201\/eid3014.240296-202411011516-R20","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid3014.240296-202411011516-R21","doi-asserted-by":"publisher","first-page":"e000076","DOI":"10.1099\/mgen.0.000076","article-title":"NGMASTER:in silico multi-antigen sequence typing for Neisseria gonorrhoeae.","volume":"2","author":"Kwong","year":"2016","journal-title":"Microb Genom"},{"key":"key-10.3201\/eid3014.240296-202411011516-R22","unstructured":"The Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 33rd edition. Supplement M100. Wayne (PA): The Institute; 2023."},{"key":"key-10.3201\/eid3014.240296-202411011516-R23","unstructured":"Centers for Disease Control and Prevention. Gonococcal Isolate Surveillance Project (GISP) and Enhanced GISP (eGISP) protocol [cited 2022 Aug 15]. https:\/\/stacks.cdc.gov\/view\/cdc\/125949"},{"key":"key-10.3201\/eid3014.240296-202411011516-R24","unstructured":"Centers for Disease Control and Prevention. Gonococcal isolate surveillance project (GISP) profiles [cited 2024 Jul 22]. https:\/\/www.cdc.gov\/sti-statistics\/gisp-profiles\/index.html"},{"key":"key-10.3201\/eid3014.240296-202411011516-R25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/OLQ.0000000000000693","article-title":"Susceptibility of Neisseria gonorrhoeae to gentamicin-gonococcal isolate surveillance project, 2015-2016.","volume":"45","author":"Mann","year":"2018","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid3014.240296-202411011516-R26","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/jac\/dkad168","article-title":"High-level in vitro resistance to gentamicin acquired in a stepwise manner in Neisseria gonorrhoeae.","volume":"78","author":"Golparian","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3014.240296-202411011516-R27","doi-asserted-by":"publisher","first-page":"e0025122","DOI":"10.1128\/aac.00251-22","article-title":"A single amino acid substitution in elongation factor G can confer low-level gentamicin resistance in Neisseria gonorrhoeae.","volume":"66","author":"Holley","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3014.240296-202411011516-R28","doi-asserted-by":"publisher","first-page":"e00996","DOI":"10.1128\/mBio.00996-20","article-title":"Cryo-EM structures of a gonococcal multidrug efflux pump illuminate a mechanism of drug recognition and resistance.","volume":"11","author":"Lyu","year":"2020","journal-title":"MBio"},{"key":"key-10.3201\/eid3014.240296-202411011516-R29","doi-asserted-by":"publisher","first-page":"ofac247","DOI":"10.1093\/ofid\/ofac247","article-title":"Phylogenomic comparison of Neisseria gonorrhoeae causing disseminated gonococcal infections and uncomplicated gonorrhea in Georgia, United States.","volume":"9","author":"Cartee","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid3014.240296-202411011516-R30","unstructured":"World Health Organization. Reporting countries (WHO-GASP) [cited 2020 Nov 12]. https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/who-gasp-reporting-countries"},{"key":"key-10.3201\/eid3014.240296-202411011516-R31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/OLQ.0000000000001678","article-title":"Neisseria gonorrhoeae Surveillance Working Group. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Peru, 2018 and 2019.","volume":"49","author":"Jorge-Berrocal","year":"2022","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid3014.240296-202411011516-R32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/09564624221147326","article-title":"Extra-genital Neisseria gonorrhoeae infections with genetic mutations conferring ciprofloxacin resistance among men who have sex with men and transgender women in Lima, Peru.","volume":"34","author":"Qquellon","year":"2023","journal-title":"Int J STD AIDS"},{"key":"key-10.3201\/eid3014.240296-202411011516-R33","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/jac\/dkad071","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review.","volume":"78","author":"Sandoval","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3014.240296-202411011516-R34","doi-asserted-by":"publisher","first-page":"e17009","DOI":"10.2196\/17009","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae in a newly implemented surveillance program in Uganda: surveillance report.","volume":"6","author":"Workneh","year":"2020","journal-title":"JMIR Public Health Surveill"},{"key":"key-10.3201\/eid3014.240296-202411011516-R35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid3014.240296-202411011516-R36","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s10903-021-01270-z","article-title":"Overseas gonorrhea screening among newly arrived refugees during 2018.","volume":"23","author":"Butler","year":"2021","journal-title":"J Immigr Minor Health"},{"key":"key-10.3201\/eid3014.240296-202411011516-R37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/IDR.S305078","article-title":"Antimicrobial resistance and human mobility.","volume":"15","author":"Desai","year":"2022","journal-title":"Infect Drug Resist"},{"key":"key-10.3201\/eid3014.240296-202411011516-R38","doi-asserted-by":"publisher","first-page":"e0206419","DOI":"10.1371\/journal.pone.0206419","article-title":"The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016.","volume":"13","author":"Sirivongrangson","year":"2018","journal-title":"PLoS One"},{"key":"key-10.3201\/eid3014.240296-202411011516-R39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","article-title":"CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024.","volume":"73","author":"Bachmann","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid3014.240296-202411011516-R40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3014.240296-202411011516-R41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/OLQ.0000000000000216","article-title":"Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study.","volume":"42","author":"Bolan","year":"2015","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid3014.240296-202411011516-R42","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"DoxyPEP Study Team. Postexposure doxycycline to prevent bacterial sexually transmitted infections.","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3014.240296-202411011516-R43","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.4102\/sajhivmed.v24i1.1510","article-title":"Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa.","volume":"24","author":"Peters","year":"2023","journal-title":"South Afr J HIV Med"},{"key":"key-10.3201\/eid3014.240296-202411011516-R44","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/infdis\/jiaa003","article-title":"Association of Neisseria gonorrhoeae plasmids with distinct lineages and the economic status of their country of origin.","volume":"222","author":"Cehovin","year":"2020","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3014.240296-202411011516-R45","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1128\/AAC.32.9.1430","article-title":"Transfer of beta-lactamase plasmids from Neisseria gonorrhoeae to Neisseria meningitidis and commensal Neisseria species by the 25.2-megadalton conjugative plasmid.","volume":"32","author":"Roberts","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid3014.240296-202411011516-R46","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s40121-023-00862-6","article-title":"Efficacy and safety of gepotidacin as treatment of uncomplicated urogenital gonorrhea (EAGLE-1): design of a randomized, comparator-controlled, phase 3 study.","volume":"12","author":"Perry","year":"2023","journal-title":"Infect Dis Ther"},{"key":"key-10.3201\/eid3014.240296-202411011516-R47","unstructured":"National Institute of Allergy and Infectious Diseases. NIH statement on preliminary efficacy results of first-in-class gonorrhea antibiotic developed through public-private partnership [cited 2023 Nov 1]. https:\/\/www.niaid.nih.gov\/news-events\/nih-statement-preliminary-efficacy-results-first-class-gonorrhea-antibiotic-developed"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/14\/24-0296_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:38:57Z","timestamp":1732905537000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/14\/24-0296_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3014.240296","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}